Related Experiment Video
Updated: May 21, 2026
09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Dose-response relationship from longitudinal data with response-dependent dose modification using likelihood methods.
Ikuko Funatogawa1, Takashi Funatogawa
1Department of Biostatistics, Vanderbilt University School of Medicine, 571 Preston Research Building, Nashville, TN 37232-6848, USA. ifunatogawa-tky@umin.ac.jp
Biometrical Journal. Biometrische Zeitschrift
|May 30, 2012
Summary
Dose adjustments in clinical trials can distort dose-response relationships. This study shows maximum-likelihood estimates are reliable when dose changes depend only on observed patient responses, ensuring accurate therapeutic assessments.
Area of Science:
- Pharmacometrics
- Clinical Trial Design
- Statistical Modeling
Background:
- Repeated therapeutic agent administration with dose adjustments based on continuous responses is common in clinical practice.
- Dose modifications driven by patient outcomes can create biased dose-response relationships, misrepresenting treatment efficacy.
- Accurate dose-response assessment is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the accuracy of dose-response relationship estimation when doses are dynamically adjusted based on patient responses.
- To determine the conditions under which statistical estimates remain consistent despite dose modification mechanisms.
- To evaluate the impact of observed versus unobserved response-based dose adjustments on estimation bias.
Main Methods:
- Utilized maximum-likelihood estimation to assess dose-response relationships.
- Developed and simulated autoregressive linear mixed-effects and linear mixed-effects models to represent patient response profiles.
- Investigated dose-modification mechanisms based on observed and unobserved responses.
Main Results:
- Maximum-likelihood estimates for the dose-response relationship are consistent when dose adjustments rely solely on observed responses.
- Simulation studies confirmed unbiased estimates under observed response-based dose modification.
- Estimates were biased when dose modifications were based on unobserved responses.
Conclusions:
- Maximum-likelihood estimation provides consistent dose-response relationship results when dose adjustments are based only on observed patient data.
- This finding is critical for accurate interpretation of therapeutic effects in adaptive clinical trials and practice.
- The study highlights the importance of the basis for dose modification in statistical modeling of treatment response.
Related Concept Videos
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...